ICD-10 Coding for Parathyroid Adenoma(C75.0, C75.0H, D35.1)
Explore comprehensive ICD-10 coding and documentation guidelines for parathyroid adenoma, including primary codes, clinical validation, and billing considerations.
Complete code families applicable to Parathyroid Adenoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D35.1 | Benign neoplasm of parathyroid gland | Use when a benign parathyroid neoplasm is confirmed without hyperparathyroidism. |
|
| E21.0 | Primary hyperparathyroidism | Use when primary hyperparathyroidism is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutParathyroid Adenoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Parathyroid Adenoma.
Vague documentation of parathyroid surgery
Impact
Clinical: Inadequate clinical information for follow-up care., Regulatory: Potential non-compliance with documentation standards., Financial: Risk of denied claims due to insufficient documentation.
Mitigation
Use detailed templates for surgical documentation, Ensure all relevant clinical data is recorded
Using E21.3 for unspecified hyperparathyroidism
Impact
Reimbursement: May lead to incorrect billing and reimbursement., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure specific diagnosis of primary or secondary hyperparathyroidism.
Histopathology Documentation
Impact
Lack of detailed histopathological confirmation can lead to audit issues.
Mitigation
Ensure all pathology reports are complete and included in patient records.